Applications in Personalized Medicine Drive Protein Analysis Market

Rising demand and US Food and Drug Administration approvals of personalized medicines are major factors driving growth of the protein analysis market. Healthcare R&D spending also plays a significant role. The market will reach USD 19.0 billion in 2023 and examines it by end use, instrumentation and reagents, services and industry type. Analysis of the entire protein complement of a cell or organism under a given set of conditions is widely used in drug discovery and clinical diagnostics. Additionally, a growing aging population and significant uptick in lifestyle diseases are factors motivating the market. Protein analysis can act as a bridge for drug discovery, customized medicines and biomarkers. From USD 11.6 billion in 2018, a five-year compound annual growth rate of 10.4 percent is projected. for approvals of protein analysis instruments have been one of the major market restraints. In addition, the high costs of these instruments affect their adoption in the industry. Both of these factors could have a negative effect on growth of the protein analysis market.

Research highlights:

• By end use, drug discovery and research accounts for the largest market share. Protein analysis has numerous applications in personalized medicine and the development of cancer biomarkers.
• Mass spectrometry dominates the instruments and reagents segment due to its popularity for handling complexities associated with the proteome. The market is divided into quantitative and laboratory services.
• Based on industry, pharmaceuticals account for the biggest market share. The adoption of protein analysis technology enables the validation and design of more effective drugs.

National governments have been revising healthcare expenditures to account for increasing R&D. As a result, research institutes will be able to obtain more government funding. BGI (China), and the Institute of Bioinformatics and Lab Surgpath (both in India), are major research institutes promoting market growth in the Asia-Pacific region. On the basis of geography, the protein analysis market is segmented into North America, Asia-Pacific, Europe, and Rest of the World. Asia-Pacific will be the fastest-growing region due to its increased protein analysis research activities. North America is still predicted to dominate the global protein analysis market due to high healthcare R&D spending and the growing demand for personalized medicines. – BCC Research